Kenya accelerates regulatory reforms to achieve WHO ML3 status
Kenya is intensifying efforts to attain the World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3 (ML3) status by December 2026, a milestone expected to strengthen pharmaceutical regulation,
Read on